Research and Development Agreement (CRADA) to advance cybersecurity innovation. The agreement enables joint research involving federal expertise, facilities and intellectual property, while an exclusive 10-year patent license gives ArmorxAI commercial rights to licensed NSA-developed security technology.
Access the resource to learn more about:
ArmorxAI’s research collaboration with the NSA
How CRADAs support public-private cybersecurity innovation
The role of federally developed security technology
ArmorxAI’s exclusive commercial licensing rights
How joint research can accelerate security capabilities